Fitxers

852405.pdf (5.19 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2024-02-26

Llicència de publicació

cc-by (c) Velasco-Hernandez, Talia et al., 2024
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/218515

Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1002/hem3.45

Resum

Relapse remains a major challenge in the clinical management of acute myeloid leukemia (AML) and is driven by rare therapy-resistant leukemia stem cells (LSCs) that reside in specific bone marrow niches. Hypoxia signaling maintains cells in a quiescent and metabolically relaxed state, desensitizing them to chemotherapy. This suggests the hypothesis that hypoxia contributes to the chemoresistance of AML-LSCs and may represent a therapeutic target to sensitize AML-LSCs to chemotherapy. Here, we identify HIFhigh and HIFlow specific AML subgroups (inv(16)/t(8;21) and MLLr, respectively) and provide a comprehensive single-cell expression atlas of 119,000 AML cells and AML-LSCs in paired diagnostic-relapse samples from these molecular subgroups. The HIF/hypoxia pathway signature is attenuated in AML-LSCs compared with more differentiated AML cells but is more expressed than in healthy hematopoietic cells. Importantly, chemical inhibition of HIF cooperates with standard-of-care chemotherapy to impair AML growth and to substantially eliminate AML-LSCs in vitro and in vivo. These findings support the HIF pathway in the stem cell-driven drug resistance of AML and unravel avenues for combinatorial targeted and chemotherapy-based approaches to specifically eliminate AML-LSCs.

Matèries

Quimioteràpia del càncer, Leucèmia, Medul·la òssia, Resistència als medicaments

Matèries (anglès)

Cancer chemotherapy, Leukemia, Bone marrow, Drug resistance

Citació

Col·leccions

Articles publicats en revistes (Ciències Fisiològiques)

Citació

ABOLLO-JIMÉNEZ, Fernando, et al. Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells. Hemasphere. 2024. Vol. 8, num. 2. ISSN 2572-9241. [consulted: 1 of June of 2026]. Available at: https://hdl.handle.net/2445/218515

Exportar metadades

JSON - METS

Compartir registre